Skip to main content

CCSG Flow Cytometry Facility

Overview

The Flow Cytometry Shared Resource provides investigators with the technological resources and professional assistance for high quality, multiparameter flow cytometry analyses and sorting. The Facility is capable of cell sorting (sterile, at speeds up to 30,000 cells/sec) from homogeneous or mixed cell populations based on up to 48 fluorochromes, sorting up to six separate populations simultaneously, including human-derived samples at BSL-2 level. Facility personnel aid investigators in creating efficient and cost-effective experimental designs, through optimizing cytometry-specific reagent and fluorochrome selection, and offer assistance in operation of analysis instruments. Technical support is also provided for analyses of flow and imaging cytometry data for publication, presentation, and inclusion in grant applications, management of cytometric data (storage, archiving, and retrieval), and management of a site license for low-cost post-acquisition analysis software.

Services

  • Multi-parameter flow cytometry analysis (up to 35 colors in traditional mode, 48 colors in spectral mode) supporting experimental protocols.
  • Fluorescence cell sorting (sterile) at rates up to 30,000 cells/second while sorting up to six populations simultaneously, utilizing 48 (FACSymphony S6 SE), 32 (MoFlo Astrios EQ), or 9 fluorescent detectors (FACSMelody), all under BSL-2 conditions if necessary. All cell sorters can perform clonal sorting into multi-well plates. Spectral cytometry is an option with the FACSymphony S6 SE.
  • Training and Consulting: Training of investigators on “user-friendly” flow cytometry instrumentation. Consulting, assisting in development of appropriate staining protocols/techniques.

Equipment & Features

Helpful Links

Pricing

For pricing information, visit iLab or contact the managing director.

This facility is supported in part by a Cancer Center Support Grant (CCSG) awarded by the National Cancer Institute (NCI) to the Ellen and Ronald Caplan Cancer Center.

See recording of facility presentation.

Selected Publications

Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1


Cusimano GM, Gary EN, Bell MR, Warner BM, Connors J, Tursi NJ, Ali AR, Zhang S, Canziani G, Taramangalam B, Gordon EA, Chaiken IM, Wootton SK, Smith T, Ramos S, Kobasa D, Weiner DB, Kutzler MA, Haddad EK. 2022.  J Immunol, 209:118-127. PMC9246991.

Ferroptosis of tumour neutrophils causes immune suppression in cancer


Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, Fu S, Sehgal M, Garcia-Gerique L, Kossenkov A, Gebregziabher BA, Tobias JW, Hicks K, Halpin RA, Cvetesic N, Deng H, Donthireddy L, Greenberg A, Nam B, Vonderheide RH, Nefedova Y, Kagan VE, Gabrilovich DI. 2022. Nature, 612:338-346. PMC9875862.

Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer


Murphy B, Miyamoto T, Manning BS, Mirji G, Ugolini A, Kannan T, Hamada K, Zhu YP, Claiborne DT, Huang L, Zhang R, Nefedova Y, Kossenkov A, Veglia F, Shinde R, Zhang N. 2024. J Exp Med, 221. PMC11586802. 

Parkin activates innate immunity and promotes antitumor immune responses


Perego M, Yeon M, Agarwal E, Milcarek AT, Bertolini I, Camisaschi C, Ghosh JC, Tang H-Y, Grandvaux N, Ruscetti M, Kossenkov AV, Preston-Alp S, Tempera I, Auslander N, Altieri DC. 2024.  J Clin Invest, 134. PMC11563675.

Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primates


Relano-Rodriguez I, Du J, Lin ZJ, Kerwin M, Tarquis-Medina M, Urbano E, Cui J, Watkins M, Zhao P, Habib R, Ghosh S, Park J, Boroughs C, Walsh AA, Melo MB, Shaw GM, Hahn BH, Irvine DJ, Wells L, Weiner DB, Kulp DW, Veazey RS, Pallesen J, Escolano A. 2025.  bioRxiv, PMC12439887.

Targeting LxCxE Cleft Pocket of Retinoblastoma Protein in Immunosuppressive Macrophages Inhibits Ovarian Cancer Progression


Tcyganov EN, Kwak T, Yang X, Poli ANR, Hart C, Bhuniya A, Cassel J, Kossenkov AV, Auslander N, Lu L, Sharma P, Cauti Mendoza MDG, Zhigarev D, Cramer GM, Cadungog MG, Jean S, Chatterjee-Paer S, Weiner DB, Donthireddy L, Bristow B, Zhang R, Tyurin VA, Tyurina YY, Bayir H, Kagan VE, Salvino JM, Montaner LJ. 2025. Cancer Immunol Res, 13:1764-1782. PMC12532034.


Contact Us

The Wistar Institute
Flow Cytometry Facility
Rooms 362-364
3601 Spruce Street
Philadelphia, PA, 19104
215-898-3811
flow_cytometry@wistar.org

Directors

Luis J. Montaner, D.V.M., M.Sc., D.Phil.
Scientific Director

Jeffrey S. Faust, B.A., M.B.A.
Managing Director

John Fundyga, B.S.
Associate Managing Director

Facility Hours

Monday-Friday
9:30 am-5:30 pm

[User-friendly analysis instruments are available 24 hours a day, 7 days a week. Hours when personnel are typically on site are shown. Appointments outside typical hours are available by appointment. Contact the facility to make arrangements.]